AB
Atara Biotherapeutics Inc
🇺🇸XNAS.ATRAUnited StatesHealthcare
$9.10USDdown -0.15 (-1.62%)OpenEnd of day2:24 PM
Price$9.10-0.15 (-1.62%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0465132068
- CUSIP
- 046513107
Company
- Employees
- 10
- Headquarters
- Thousand Oaks, United States
- Website
- https://www.atarabio.com
- CEO
- Dr. Anhco Nguyen Ph.D.
Market
- Shares outstanding
- 10M
- Market cap
- $91.34M
Highlights
- Market cap
- $91.34M
- EPS LTM
- -$1.11
- P/E LTM
- -10.34
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $6.19M-96.72%down year on year
- Net income
- -$16.69M-387.97%down year on year
- Gross margin
- 91.38%+12.48%up year on year
- Free cash flow
- -$21.9M+65.79%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.